Foto: Laura Gochicoa, Präsidentin der Global Lung Initiative (GLI), und Sundeep Salvi, Global Director der Global Initiative for Chronic Obstructive Pulmonary Disease (GOLD), besuchten den Sunvou-Stand

At the American Thoracic Society (ATS) 2025 International Meeting, held in San Francisco, USA from May 16 to 21, 2025, Sunvou Medical showcased the world's first clinical combined breath test device, which garnered widespread attention from participants and professionals attending the event. Leading respiratory experts from North America, Europe, and other regions, after experiencing the technology firsthand and learning about its clinical applications, stated that the product “provides a completely new and complete solution for the clinical diagnosis of airway diseases.”

During the exhibition, the innovative device attracted considerable interest from clinicians, researchers, and industry representatives who were eager to explore its potential role in improving respiratory disease assessment and patient management. Academic leaders from international organizations such as GINA, GOLD, and GLI expressed their willingness to collaborate with Sunvou Medical to jointly develop standards for innovative technologies, promote the harmonization of clinical practices, standardize the clinical use of related tests, and maximize their clinical value in routine respiratory care.

Foto: Gregory Downey, ehemaliger Präsident der American Thoracic Society (ATS), besuchte den Sunvou-Stand

Die Lösungen von Sunvou Medical für die Primärversorgung und die Überwachung der Atemwege zu Hause fanden ebenfalls große Beachtung, und mehrere internationale medizinische Einrichtungen führten bereits Gespräche über die Einführung von Produkten. Diese Messe hat die führende Position von Sunvou in der globalen Atemwegsdiagnose und -behandlung weiter gefestigt.